Eisen-Suppressed-Inventions-and-other-Discoveries-True-Stories-of ...

AIDS and Ebola:
Where Did
They Really
Come From
Dr. Leonard G. Horowitz
During the 1960s and early 1970s the World Health Organization functioned
as the omnipotent supplier and standardizing authority of the world's
experimental pharmaceuticals. In the field of virology, the United States
Public Health Service (USPHS) and National Institutes of Health (NIH)
directed the National Cancer Institute (NCI) to become, along with the
Centers for Disease Control and Prevention (CDC) the WHO's chief distributor
of viruses and antiviral vaccines. The WHO Chronicle noted by
1968—ten years into the WHO's viral research program—"WHO virus
reference centres" had served as authorized technical advisors and suppliers
of "prototype virus strains, diagnostic and reference reagents (e.g.,
antibodies), antigens, and cell cultures" for more than "120 laboratories in
35 different countries." Within a year of this announcement, this number
increased to "592 virus laboratories . . . [and] only 137 were outside
Europe and North America." Over these 12 months, the NCI and CDC
helped the WHO distribute 2,514 strains of viruses, 1,888 ampoules of
antisera mainly for reference purposes, 1,274 ampoules of antigens, and
about 100 samples of cell cultures. More than 70,000 individual reports of
virus isolations or related serological tests had been transmitted through
the WHO-NCI network. 12
At the NCI in Bethesda, Maryland, from the late 1960s to the present,
the chief retrovirus research laboratory was associated with the Department
of Cell Tumor Biology, and chaired by Dr. Robert Gallo—an
esteemed member of the National Academy of Sciences (NAS) who was
hailed by the U.S. Secretary of Health and Human Services Margaret
Heckler in 1984 as the discoverer of the AIDS virus, HTLV-III. LAV,
identical to HTLV-III had been isolated by Montagnier's French team and
allegedly forwarded to Gallo in 1983. 3